Michael Lalezarian
Vascular & Interventional Radiology · Los Angeles, CANPI 1023245230
Payments from drug & device makers
Across 436 payments — averaging $179.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$45K
- Boston Scientific$19K
- Medtronic$3K
- Abbott$3K
- Cordis US CORP.$3K
- Cardiovascular Systems Inc.$739
- plus $4K from 20 others
What the payments were for
- Consulting fees$2,7003%
- Speaking & faculty fees$18,65324%
- Travel & lodging$9341%
- Food & beverage$15,11419%
- Education$2280%
- Other$40,66752%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 112 | $45,383 |
| Boston Scientific | 37 | $19,025 |
| Medtronic(2 entities) | 89 | $3,378 |
| Abbott | 64 | $3,098 |
| Cordis US CORP. | 17 | $3,049 |
| Cardiovascular Systems Inc. | 22 | $739 |
| Nevro Corp. | 23 | $688 |
| Okami Medical, Inc. | 3 | $583 |
| Cook Medical LLC | 22 | $423 |
| Globus Medical | 11 | $354 |
| Philips North America LLC | 4 | $334 |
| Bard Peripheral Vascular, Inc. | 13 | $191 |
| Balt USA, LLC | 1 | $178 |
| Cagent Vascular Inc | 2 | $158 |
| Organogenesis Inc. | 1 | $123 |
| AstraZeneca | 1 | $118 |
| Avantec Vascular Corporation | 1 | $107 |
| Terumo Medical Corporation | 1 | $93 |
| Johnson & Johnson | 3 | $64 |
| VYNE Pharmaceuticals Inc. | 2 | $53 |
| Mimedx Group, Inc. | 2 | $52 |
| Venclose Inc. | 1 | $28 |
| Solventum Corporation | 1 | $24 |
| BD | 1 | $24 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $14 |
| Saluda Medical Americas, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$43,149
- Varithena Administration Pack$18,653
- Omnilink Elite vascular stent system$1,256
- LOBO$583
- HawkOne$549
- Senza$462
- TurboHawk$388
- IN.PACT Admiral$385
- SilverHawk$350
- (5044) MCOT$254
- Peripheral Orbital Atherectomy System$217
- Prestige Coil System$178
- Supera peripheral stent system$171
- Abre$168
- VenaSeal$160
- SUPERA$147
- PURAPLY WOUND MATRIX$123
- Diamondback Peripheral$123
- SpiderFX$116
- Serrantor$115
How this compares
$78,295 in reported general payments places this provider in the 85th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 135 | $137,749 |
| ClopidogrelClopidogrel Bisulfate | 24 | $258 |
| Gabapentin | 16 | $136 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $64 | $137,749135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 504 vascular & interventional radiology providers in California.
Other vascular & interventional radiology in Los Angeles
- Keith TerasakiLos Angeles$1.7M
- Edward LeeLos Angeles$1.7M
- Siddharth PadiaLos Angeles$1.6M
- Satoshi TateshimaLos Angeles$921K
- John MoriartyLos Angeles$719K
- Navid EghbaliehLos Angeles$639K
- Steven RamanLos Angeles$419K
- Justin McWilliamsLos Angeles$355K
- Jessica StewartLos Angeles$322K
- Ravi SrinivasaLos Angeles$279K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.